Sebastian Meltzer

15PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsMedical virologyDeep learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 20, 2026
Pooled analysis of 2 clinical trials of first-line chemoimmunotherapy for metastatic microsatellite stable colorectal cancer MEDITREME and METIMMOX studies.

|May 20, 2026
Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer - A Post Hoc Analysis of METIMMOX Trial Data.

|Feb 23, 2026
Exploratory biomarkers for oxaliplatin-induced nivolumab responsiveness in metastatic microsatellite-stable colorectal cancer.

Anne Hansen Ree, Paula A Bousquet, Tina Visnovska

|Feb 10, 2026
Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial.

Kathinka Schmidt Slørdahl, Katarina Puco, Ragnhild Sørum Falk

|Oct 19, 2025
Low b-values in apparent diffusion coefficient calculations overestimate diffusion in rectal cancer.

Johanna A Hundvin, Marius Bornstein, Anne Negård

|Apr 27, 2025
Serum metabolite levels identify incipient metastatic progression of rectal cancer.

Kine M Bakke, Paula A Bousquet, Sebastian Meltzer

Pageof 3

Frequent Collaborators

14 joint publications

Anne Hansen Ree

6 joint publications

Kathrine Røe Redalen

4 joint publications

Anne Negård

2 joint publications

Kine M Bakke